1. Academic Validation
  2. Protein arginine methyltransferase 3: A crucial regulator in metabolic reprogramming and gene expression in cancers

Protein arginine methyltransferase 3: A crucial regulator in metabolic reprogramming and gene expression in cancers

  • Cancer Lett. 2023 Feb 1:554:216008. doi: 10.1016/j.canlet.2022.216008.
Shih-Han Hsu 1 Wen-Chun Hung 2
Affiliations

Affiliations

  • 1 National Institute of Cancer Research, National Health Research Institutes, Tainan, 704, Taiwan.
  • 2 National Institute of Cancer Research, National Health Research Institutes, Tainan, 704, Taiwan; School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, 802, Taiwan. Electronic address: [email protected].
Abstract

Post-translational modification (PTM) of proteins increases proteome diversity, which is critical for maintaining cellular homeostasis. The importance of protein methylation in the regulation of diverse biological processes has been highlighted in the past decades. Methylation of the arginine residue on proteins is catalyzed by members of the protein arginine methyltransferase (PRMT) family. PRMTs play indispensable roles in various pathways that regulate Cancer development, progression, and drug response. In this review, we discuss the role of PRMT3, a member of the PRMT family, in controlling oncogenic processes. Additionally, the effects of PRMT3 on the methylation of regulatory proteins involved in transcription, post-transcriptional control, ribosomal maturation, translation, biological synthesis, and metabolic signaling are summarized. Moreover, recent progresses in the development of PRMT3 inhibitors are introduced. Overall, this review highlights the importance of PRMT3 in tumorigenesis and discusses the underlying mechanisms by which PRMT3 modulates cellular metabolism and gene expression. These results also provide a molecular basis for therapeutic modalities by targeting PRMT3.

Keywords

Cellular metabolism; PRMT3; Post-translational modification; Transcriptional factor.

Figures